{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:29:48Z","timestamp":1790188188842,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T00:00:00Z","timestamp":1585267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T00:00:00Z","timestamp":1585267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ17H190005"],"award-info":[{"award-number":["LQ17H190005"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Public Technology Applied Research Foundation of Zhejiang Province of China","award":["LGF18H060009"],"award-info":[{"award-number":["LGF18H060009"]}]},{"name":"the Administration of Zhejiang Traditional Chinese Medicine","award":["2016ZA136"],"award-info":[{"award-number":["2016ZA136"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472055"],"award-info":[{"award-number":["81472055"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672129"],"award-info":[{"award-number":["81672129"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Research and Development Program of Zhejiang Province","award":["2019C03023"],"award-info":[{"award-number":["2019C03023"]}]},{"name":"Zhejiang College Students Innovative Entrepreneurial Training Program","award":["2018R413011"],"award-info":[{"award-number":["2018R413011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammation and joint stiffness, finally leading to tissue destruction. Connective tissue growth factor (CTGF) is a critical factor in RA progression, which promotes fibroblast-like synoviocyte (FLS) proliferation, pannus formation, and the damage of cartilage as well as bone. Resolvin D1 (RvD1) can promote inflammation resolution in acute inflammatory diseases, and recently, effects of RvD1 on chronic inflammatory diseases also attracted attention. This study aimed to examine the effect of RvD1 on pannus formation in RA and the underlying mechanism.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Serum levels of RvD1 and CTGF were determined in RA patients and healthy persons by UPLC-MS\/MS and ELISA respectively. The levels of CTGF and inflammatory factors were assessed by qRT-PCR and ELISA. MicroRNA expression profile was determined by miRNA microarray. The effects of CTGF, RvD1, and miR-146a-5p on angiogenesis were evaluated with tube formation and chick chorioallantoic membrane (CAM) assays. Collagen-induced arthritis (CIA) mice were constructed to detect the effects of RvD1 and miR146a-5p on RA. STAT3 activation was determined by Western blotting.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>RvD1 levels decreased while CTGF levels increased in RA patients\u2019 serum, and an inverse correlation of the concentrations of RvD1 and CTGF in the serum of RA patients was synchronously observed. In CIA mice, RvD1 suppressed angiopoiesis and decreased the expression of CTGF. Simultaneously, RvD1 significantly decreased CTGF and pro-inflammation cytokines levels in RA FLS. Furthermore, CTGF suppressed angiopoiesis and RvD1 inhibited the proliferation and migration of RA FLS and angiopoiesis. MiRNA microarray and qRT-PCR results showed that RvD1 upregulated miRNA-146a-5p. The transfection experiments demonstrated that miRNA-146a-5p could decrease inflammatory factors and CTGF levels. Moreover, miRNA-146a-5p decreased the proliferation of FLS and angiogenesis in vivo. MiRNA-146a-5p also suppressed angiogenesis and downregulated the expression of CTGF in CIA mice. Finally, Western blot results revealed that miRNA-146a-5p inhibited the activation of STAT3.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>RvD1 is prone to alleviate RA progression through the upregulation of miRNA-146a-5p to suppress the expression of CTGF and inflammatory mediators, thereby decreasing pannus formation and cartilage damage.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-020-2133-2","type":"journal-article","created":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T03:04:36Z","timestamp":1585278276000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Resolvin D1 suppresses pannus formation via decreasing connective tissue growth factor caused by upregulation of miRNA-146a-5p in rheumatoid arthritis"],"prefix":"10.1186","volume":"22","author":[{"given":"Weiwei","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chipeng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanzhi","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengwei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,27]]},"reference":[{"key":"2133_CR1","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13075-015-0637-y","volume":"17","author":"XY Yang","year":"2015","unstructured":"Yang XY, Qiu PC, Chen BB, Lin YY, Zhou ZH, Ge RS, et al. KIAA1199 as a potential diagnostic biomarker of rheumatoid arthritis related to angiogenesis. Arthritis Res Ther. 2015;17:140..","journal-title":"Arthritis Res Ther"},{"key":"2133_CR2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/ar113","volume":"2","author":"T Pap","year":"2000","unstructured":"Pap T, Muller-Ladner U, Gay RE, Gay S. Fibroblast biology: role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res. 2000;2:361\u20137.","journal-title":"Arthritis Res"},{"key":"2133_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrrheum.2012.190","volume":"9","author":"N Bottini","year":"2013","unstructured":"Bottini N, Firestein GS. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol. 2013;9:24\u201333.","journal-title":"Nat Rev Rheumatol"},{"key":"2133_CR4","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/art.33425","volume":"64","author":"JG Wang","year":"2012","unstructured":"Wang JG, Xu WD, Zhai WT, Li Y, Hu JW, Hu B, et al. Disorders in angiogenesis and redox pathways are main factors contributing to the progression of rheumatoid arthritis. Arthritis Rheum. 2012;64:993\u20131004.","journal-title":"Arthritis Rheum"},{"key":"2133_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13075-017-1463-1","volume":"19","author":"XY Yang","year":"2017","unstructured":"Yang XY, Lin K, Ni SM, Wang JM, Tian QQ, Chen HJ, et al. Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis. Arthritis Res Ther. 2017;19:257.","journal-title":"Arthritis Res Ther"},{"key":"2133_CR6","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1002\/art.37902","volume":"65","author":"K Nozawa","year":"2013","unstructured":"Nozawa K, Fujishiro M, Kawasaki M, Yamaguchi A, Ikeda K, Morimoto S, et al. Inhibition of connective tissue growth factor ameliorates disease in a murine model of rheumatoid arthritis. Arthritis Rheum. 2013;65:1477\u201386.","journal-title":"Arthritis Rheum"},{"key":"2133_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature13479","volume":"510","author":"CN Serhan","year":"2014","unstructured":"Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510:92\u2013101.","journal-title":"Nature"},{"key":"2133_CR8","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1084\/jem.20020760","volume":"196","author":"CN Serhan","year":"2002","unstructured":"Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med. 2002;196:1025\u201337.","journal-title":"J Exp Med"},{"key":"2133_CR9","doi-asserted-by":"publisher","first-page":"9323","DOI":"10.1074\/jbc.M609212200","volume":"282","author":"YP Sun","year":"2007","unstructured":"Sun YP, Oh SF, Uddin J, Yang R, Gotlinger K, Campbell E, et al. Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J Biol Chem. 2007;282:9323\u201334.","journal-title":"J Biol Chem"},{"key":"2133_CR10","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1161\/ATVBAHA.112.249508","volume":"32","author":"LV Norling","year":"2012","unstructured":"Norling LV, Dalli J, Flower RJ, Serhan CN, Perretti M. Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions. Arterioscler Thromb Vasc Biol. 2012;32:1970\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2133_CR11","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1073\/pnas.0907342107","volume":"107","author":"S Krishnamoorthy","year":"2010","unstructured":"Krishnamoorthy S, Recchiuti A, Chiang N, Yacoubian S, Lee CH, et al. Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci U S A. 2010;107:1660\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2133_CR12","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.4049\/jimmunol.1502268","volume":"197","author":"HH Arnardottir","year":"2016","unstructured":"Arnardottir HH, Dalli J, Norling LV, Colas RA, Perretti M, Serhan CN. Resolvin D3 is dysregulated in arthritis and reduces arthritic inflammation. J Immunol. 2016;197:2362\u20138.","journal-title":"J Immunol"},{"key":"2133_CR13","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1476-5381.2011.01345.x","volume":"164","author":"JF Lima-Garcia","year":"2011","unstructured":"Lima-Garcia JF, Dutra RC, da Silva K, Motta EM, Campos MM, Calixto JB. The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats. Br J Pharmacol. 2011;164:278\u201393.","journal-title":"Br J Pharmacol"},{"key":"2133_CR14","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1096\/fj.10-169599","volume":"25","author":"A Recchiuti","year":"2011","unstructured":"Recchiuti A, Krishnamoorthy S, Fredman G, Chiang N, Serhan CN. MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits. FASEB J. 2011;25:544\u201360.","journal-title":"FASEB J"},{"key":"2133_CR15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/jbmr.3005","volume":"32","author":"Y Maeda","year":"2016","unstructured":"Maeda Y, Farina NH, Matzelle MM, Fanning PJ, Lian JB, Gravallese EM. Synovium-derived microRNAs regulate bone pathways in rheumatoid arthritis. J Bone Miner Res. 2016;32:461\u201372.","journal-title":"J Bone Miner Res"},{"key":"2133_CR16","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1038\/nm.2815","volume":"18","author":"S Zhu","year":"2012","unstructured":"Zhu S, Pan W, Song X, Liu Y, Shao X, Tang Y, et al. The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-\u03b1. Nat Med. 2012;18:1077\u201386.","journal-title":"Nat Med"},{"key":"2133_CR17","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1136\/annrheumdis-2018-213511","volume":"77","author":"SW Jin","year":"2018","unstructured":"Jin SW, Chen HJ, Li YS, Zhong H, Sun WW, Wang JM, et al. Maresin 1 improves the Treg\/Th17 imbalance in rheumatoid arthritis through miR-21. Ann Rheum Dis. 2018;77:1644\u201352.","journal-title":"Ann Rheum Dis"},{"key":"2133_CR18","doi-asserted-by":"crossref","unstructured":"English JT, Norris PC, Hodges RR, Dartt DA, Serhan CN. Identification and profiling of specialized pro-resolving mediators in human tears by lipid mediator metabolomics. Prostaglandins Leukot Essent Fatty Acids 2017;117:17\u20137.","DOI":"10.1016\/j.plefa.2017.01.004"},{"key":"2133_CR19","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1002\/art.23063","volume":"56","author":"JJ Inglis","year":"2007","unstructured":"Inglis JJ, Notley CA, Essex D, Wilson AW, Feldmann M, Anand P, et al. Collagen-induced arthritis as a model of hyperalgesia: functional and cellular analysis of the analgesic actions of tumor necrosis factor blockade. Arthritis Rheum. 2007;56:4015\u201323.","journal-title":"Arthritis Rheum"},{"key":"2133_CR20","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00011-017-1027-5","volume":"66","author":"M Huang","year":"2017","unstructured":"Huang M, Wang L, Zeng S, Qiu Q, Zou Y, Shi M, et al. Indirubin inhibits the migration, invasion, and activation of fibroblast-like synoviocytes from rheumatoid arthritis patients. Inflamm Res. 2017;66:433\u201340.","journal-title":"Inflamm Res"},{"key":"2133_CR21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/978-1-4939-0320-7_32","volume":"1135","author":"S Guo","year":"2014","unstructured":"Guo S, Lok J, Liu Y, Hayakawa K, Leung W, Xing C, et al. Assays to examine endothelial cell migration, tube formation, and gene expression profiles. Methods Mol Biol. 2014;1135:393\u2013402.","journal-title":"Methods Mol Biol"},{"key":"2133_CR22","first-page":"20","volume":"26","author":"K Zabielska-Koczyw\u0105s","year":"2017","unstructured":"Zabielska-Koczyw\u0105s K, Wojtkowska A, Dolka I, Ma\u0142ek A, Walewska M, Wojtalewicz A, et al. 3D chick embryo chorioallantoic membrane model as an in vivo model to study morphological and histopathological features of feline fibrosarcomas. BMC Vet Res. 2017;26:20.","journal-title":"BMC Vet Res"},{"key":"2133_CR23","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1164\/rccm.200311-1535OC","volume":"171","author":"WE Lawson","year":"2005","unstructured":"Lawson WE, Polosukhin VV, Zoia O, Stathopoulos GT, Han W, Plieth D, et al. Characterization of fibroblast-specific protein 1 in pulmonary fibrosis. Am J Respir Crit Care Med. 2005;171:899\u2013907.","journal-title":"Am J Respir Crit Care Med"},{"key":"2133_CR24","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","volume":"117","author":"CA Dinarello","year":"2011","unstructured":"Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 2011;117:3720\u201332.","journal-title":"Blood"},{"key":"2133_CR25","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1002\/art.33468","volume":"64","author":"M Brenner","year":"2012","unstructured":"Brenner M, Laragione T, Shah A, Mello A, Remmers EF, Wilder RL, et al. Identification of two new arthritis severity loci that regulate levels of autoantibodies, interleukin-1\u03b2, and joint damage in pristane- and collagen-induced arthritis. Arthritis Rheum. 2012;64:1369\u201378.","journal-title":"Arthritis Rheum"},{"key":"2133_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/intimm\/dxu102","volume":"27","author":"C Monaco","year":"2015","unstructured":"Monaco C, Nanchahal J, Taylor P, Feldmann M. Anti-TNF therapy: past, present and future. Int Immunol. 2015;27:55\u201362.","journal-title":"Int Immunol"},{"key":"2133_CR27","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1136\/annrheumdis-2017-211286","volume":"76","author":"A Filer","year":"2017","unstructured":"Filer A, LSC W, Kemble S, Davies CS, Munir H, Rogers R, et al. Identification of a transitional fibroblast function in very early rheumatoid arthritis. Ann Rheum Dis. 2017;76:2105\u201312.","journal-title":"Ann Rheum Dis"},{"key":"2133_CR28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S0140-6736(03)15172-0","volume":"363","author":"B Perbal","year":"2004","unstructured":"Perbal B. CCN proteins: multifunctional signalling regulators. Lancet. 2004;363:62\u20134.","journal-title":"Lancet"},{"key":"2133_CR29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/jcp.10206","volume":"194","author":"M Takigawa","year":"2003","unstructured":"Takigawa M, Nakanishi T, Kubota S, Nishida T. Role of CTGF\/HCS24\/ecogenin in skeletal growth control. J Cell Physiol. 2003;194:256\u201366.","journal-title":"J Cell Physiol"},{"key":"2133_CR30","doi-asserted-by":"publisher","first-page":"R174","DOI":"10.1186\/ar2863","volume":"11","author":"K Nozawa","year":"2009","unstructured":"Nozawa K, Fujishiro M, Kawasaki M, Kaneko H, Iwabuchi K, Yanagida M, et al. Connective tissue growth factor promote articular damage by increased osteoclastogenesis in patients with rheumatoid arthritis. Arthritis Res Ther. 2009;11:R174.","journal-title":"Arthritis Res Ther"},{"key":"2133_CR31","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3109\/03009742.2015.1092581","volume":"45","author":"S Ding","year":"2016","unstructured":"Ding S, Duan H, Fang F, Shen H, Xiao W. CTGF promotes articular damage by increased proliferation of fibroblast-like synoviocytes in rheumatoid arthritis. Scand J Rheumatol. 2016;45:282\u20137.","journal-title":"Scand J Rheumatol"},{"key":"2133_CR32","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1084\/jem.20101823","volume":"208","author":"MP Boldin","year":"2011","unstructured":"Boldin MP, Taganov KD, Rao DS, Yang LL, Zhao JL, Kalwani M, et al. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med. 2011;208:1189\u2013201.","journal-title":"J Exp Med"},{"key":"2133_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13075-018-1546-7","volume":"20","author":"QB Zhang","year":"2018","unstructured":"Zhang QB, Qing YF, Yin CC, Zhou L, Liu XS, Mi QS, et al. Mice with miR-146a deficiency develop severe gouty arthritis via dysregulation of TRAF 6, IRAK 1 and NALP3 inflammasome. Arthritis Res Ther. 2018;20:45.","journal-title":"Arthritis Res Ther"},{"key":"2133_CR34","doi-asserted-by":"publisher","first-page":"5972","DOI":"10.7150\/thno.29313","volume":"8","author":"M Ammari","year":"2018","unstructured":"Ammari M, Presumey J, Ponsolles C, Roussigno G, Roubert C, Escriou V, et al. Delivery of miR-146a to Ly6Chigh monocytes inhibits pathogenic bone Erosion in inflammatory arthritis. Theranostics. 2018;8:5972\u201385.","journal-title":"Theranostics"},{"key":"2133_CR35","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1002\/art.30321","volume":"63","author":"T Nakasa","year":"2011","unstructured":"Nakasa T, Shibuya H, Nagata Y, Niimoto T, Ochi M. The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis. Arthritis Rheum. 2011;63:1582\u201390.","journal-title":"Arthritis Rheum"},{"key":"2133_CR36","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.canlet.2018.06.038","volume":"433","author":"T Notarangelo","year":"2018","unstructured":"Notarangelo T, Sisinni L, Trino S, Calice G, Simeon V, Landriscina M. IL6\/STAT3 axis mediates resistance to BRAF inhibitors in thyroid carcinoma cells. Cancer Lett. 2018;433:147\u201355.","journal-title":"Cancer Lett"},{"key":"2133_CR37","doi-asserted-by":"publisher","first-page":"30708","DOI":"10.1074\/jbc.M113.478685","volume":"288","author":"Y Liu","year":"2013","unstructured":"Liu Y, Liu H, Meyer C, Li J, Nadalin S, K\u00f6nigsrainer A, et al. Transforming growth factor-\u03b2 (TGF-\u03b2)-mediated connective tissue growth factor (CTGF) expression in hepatic stellate cells requires Stat3 signaling activation. J Biol Chem. 2013;288:30708\u201319.","journal-title":"J Biol Chem"},{"key":"2133_CR38","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.canlet.2018.05.044","volume":"431","author":"L IKY","year":"2018","unstructured":"IKY L, Chow JX, Lau CS, VSF C. MicroRNA-mediated immune regulation in rheumatic diseases. Cancer Lett. 2018;431:201\u201312.","journal-title":"Cancer Lett"},{"key":"2133_CR39","doi-asserted-by":"publisher","first-page":"11193","DOI":"10.1073\/pnas.1019536108","volume":"108","author":"M Kurowska-Stolarska","year":"2011","unstructured":"Kurowska-Stolarska M, Alivernini S, Ballantine LE, Asquith DL, Millar NL, Gilchrist DS, et al. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Natl Acad Sci U S A. 2011;108:11193\u20138.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-2133-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-020-2133-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-2133-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T00:15:03Z","timestamp":1616804103000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-020-2133-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,27]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2133"],"URL":"https:\/\/doi.org\/10.1186\/s13075-020-2133-2","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,27]]},"assertion":[{"value":"25 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Sera were acquired from RA patients and healthy controls at the First Affiliated Hospital of Wenzhou Medical University. This study was approved by the Clinical Research Ethics Committees of the First Affiliated Hospital of Wenzhou Medical University (No. 2016157). All patients participated in this study provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}